Novavax
NVAX • NASDAQ
Novavax is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO John Charles Jacobs, with a market cap of $1.4B.
Market Cap$1.4B
Employees2.0K
CEOJohn Charles Jacobs
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 14, 2026 · In 2 weeksBefore Market Open · Q1 2026
Financials
Novavax FAQ
Common questions about Novavax
Novavax is scheduled to report earnings for Q1 2026 on May 14, 2026 before market open. Analysts estimate revenue of $79.4M.
Novavax has approximately 1,992 employees.